vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
PARK NATIONAL CORP is the larger business by last-quarter revenue ($168.3M vs $148.6M, roughly 1.1× Azenta, Inc.). PARK NATIONAL CORP runs the higher net margin — 25.3% vs -10.4%, a 35.7% gap on every dollar of revenue. On growth, PARK NATIONAL CORP posted the faster year-over-year revenue change (2.2% vs 0.8%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $14.7M). Over the past eight quarters, PARK NATIONAL CORP's revenue compounded faster (4.9% CAGR vs 4.4%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
AZTA vs PRK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $168.3M |
| Net Profit | $-15.4M | $42.6M |
| Gross Margin | 42.9% | — |
| Operating Margin | -4.9% | — |
| Net Margin | -10.4% | 25.3% |
| Revenue YoY | 0.8% | 2.2% |
| Net Profit YoY | -15.7% | 10.4% |
| EPS (diluted) | $-0.34 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $168.3M | ||
| Q3 25 | $159.2M | $169.5M | ||
| Q2 25 | $143.9M | $168.7M | ||
| Q1 25 | $143.3M | $157.9M | ||
| Q4 24 | $147.4M | $164.7M | ||
| Q3 24 | $150.6M | $170.3M | ||
| Q2 24 | $144.3M | $157.7M | ||
| Q1 24 | $136.4M | $152.8M |
| Q4 25 | $-15.4M | $42.6M | ||
| Q3 25 | $50.9M | $47.2M | ||
| Q2 25 | $-48.0M | $48.1M | ||
| Q1 25 | $-47.7M | $42.2M | ||
| Q4 24 | $-11.0M | $38.6M | ||
| Q3 24 | $-6.6M | $38.2M | ||
| Q2 24 | $-6.6M | $39.4M | ||
| Q1 24 | $-137.4M | $35.2M |
| Q4 25 | 42.9% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 46.2% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 46.7% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 44.8% | — | ||
| Q1 24 | 43.8% | — |
| Q4 25 | -4.9% | — | ||
| Q3 25 | 1.2% | 34.3% | ||
| Q2 25 | -1.3% | 35.2% | ||
| Q1 25 | -12.7% | 32.4% | ||
| Q4 24 | -5.9% | — | ||
| Q3 24 | -3.1% | 27.4% | ||
| Q2 24 | -4.9% | 30.6% | ||
| Q1 24 | -18.1% | 27.8% |
| Q4 25 | -10.4% | 25.3% | ||
| Q3 25 | 32.0% | 27.8% | ||
| Q2 25 | -33.4% | 28.5% | ||
| Q1 25 | -33.3% | 26.7% | ||
| Q4 24 | -7.5% | 23.5% | ||
| Q3 24 | -4.4% | 22.4% | ||
| Q2 24 | -4.5% | 25.0% | ||
| Q1 24 | -100.8% | 23.0% |
| Q4 25 | $-0.34 | $2.62 | ||
| Q3 25 | $1.12 | $2.92 | ||
| Q2 25 | $-1.05 | $2.97 | ||
| Q1 25 | $-1.04 | $2.60 | ||
| Q4 24 | $-0.25 | $2.38 | ||
| Q3 24 | $-0.25 | $2.35 | ||
| Q2 24 | $-0.12 | $2.42 | ||
| Q1 24 | $-2.48 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $1.4B |
| Total Assets | $2.1B | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $233.5M | ||
| Q3 25 | $279.8M | $218.9M | ||
| Q2 25 | $270.0M | $193.1M | ||
| Q1 25 | $253.6M | $237.6M | ||
| Q4 24 | $377.5M | $160.6M | ||
| Q3 24 | $280.0M | $201.7M | ||
| Q2 24 | $336.5M | $261.5M | ||
| Q1 24 | $353.5M | $306.1M |
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.8B | $1.2B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.2B | $1.2B |
| Q4 25 | $2.1B | $9.8B | ||
| Q3 25 | $2.1B | $9.9B | ||
| Q2 25 | $2.0B | $9.9B | ||
| Q1 25 | $2.0B | $9.9B | ||
| Q4 24 | $2.0B | $9.8B | ||
| Q3 24 | $2.1B | $9.9B | ||
| Q2 24 | $2.3B | $9.9B | ||
| Q1 24 | $2.6B | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $198.3M |
| Free Cash FlowOCF − Capex | $14.7M | $191.9M |
| FCF MarginFCF / Revenue | 9.9% | 114.1% |
| Capex IntensityCapex / Revenue | 4.2% | 3.8% |
| Cash ConversionOCF / Net Profit | — | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $198.3M | ||
| Q3 25 | $2.2M | $52.6M | ||
| Q2 25 | $25.8M | $49.7M | ||
| Q1 25 | $14.4M | $37.9M | ||
| Q4 24 | $29.8M | $178.8M | ||
| Q3 24 | $17.7M | $43.8M | ||
| Q2 24 | $9.8M | $50.9M | ||
| Q1 24 | $8.7M | $35.0M |
| Q4 25 | $14.7M | $191.9M | ||
| Q3 25 | $-5.7M | $51.1M | ||
| Q2 25 | $15.0M | $48.4M | ||
| Q1 25 | $7.0M | $36.8M | ||
| Q4 24 | $22.0M | $169.7M | ||
| Q3 24 | $8.3M | $41.7M | ||
| Q2 24 | $1.3M | $49.0M | ||
| Q1 24 | $428.0K | $31.9M |
| Q4 25 | 9.9% | 114.1% | ||
| Q3 25 | -3.6% | 30.1% | ||
| Q2 25 | 10.4% | 28.7% | ||
| Q1 25 | 4.9% | 23.3% | ||
| Q4 24 | 15.0% | 103.0% | ||
| Q3 24 | 5.5% | 24.5% | ||
| Q2 24 | 0.9% | 31.1% | ||
| Q1 24 | 0.3% | 20.8% |
| Q4 25 | 4.2% | 3.8% | ||
| Q3 25 | 4.9% | 0.9% | ||
| Q2 25 | 7.5% | 0.8% | ||
| Q1 25 | 5.2% | 0.7% | ||
| Q4 24 | 5.3% | 5.6% | ||
| Q3 24 | 6.2% | 1.2% | ||
| Q2 24 | 5.9% | 1.2% | ||
| Q1 24 | 6.1% | 2.1% |
| Q4 25 | — | 4.65× | ||
| Q3 25 | 0.04× | 1.11× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 4.63× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
PRK
Segment breakdown not available.
